Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Scientific Reports|November 29, 2019
Identification of potential molecular pathogenesis mechanisms modulated by microRNAs in patients with Intestinal Neuronal Dysplasia type BMarcos C Angelini, Alana Maia E Silva, Tainara F Felix, et al.
Bioresource Technology|May 20, 2009
Modification of wheat straw lignin by solid state fermentation with white-rot fungiMaria J Dinis, Rui M F Bezerra, Fernando Nunes, et al.
Digestive Diseases and Sciences|May 24, 2007
Relationship among oxidative DNA damage, gastric mucosal density and the relevance of cagA, vacA and iceA genotypes of Helicobacter pyloriMarcelo S P Ladeira, Roberta C A Bueno, Bruna Fornazari Dos Santos, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|April 5, 2017
Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagusC F Lacerda, A Cruvinel-Carloni, A T Torres de Oliveira, et al.
Studies in Mycology|January 14, 2022
Trends in the molecular epidemiology and population genetics of emerging <i>Sporothrix</i> speciesJ A de Carvalho, M A Beale, F Hagen, et al.
Transplantation Proceedings|October 3, 2012
Effect of ischemic preconditioning on injuries caused by ischemia and reperfusion in rat intestineM O Taha, R Miranda-Ferreira, A C R Chang, et al.
Studies in Mycology|December 18, 2020
The global epidemiology of emerging <i>Histoplasma</i> species in recent yearsA M Rodrigues, M A Beale, F Hagen, et al.
Mucosal Immunology|October 4, 2018
CLA-supplemented diet accelerates experimental colorectal cancer by inducing TGF-β-producing macrophages and T cellsT G Moreira, L S Horta, A C Gomes-Santos, et al.
Persoonia|January 30, 2016
Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reportsY Zhang, F Hagen, B Stielow, et al.
Scandinavian Journal of Rheumatology|May 21, 2024
Enthesitis in a European registry-based cohort of patients with psoriatic arthritis treated with tumour necrosis factor inhibitors: clinical burden, patient-reported outcomes, and treatment responseA J Mathew, M L Hetland, M P Pedersen, et al.
Pageof 10